By Lucy Parkinson, VP of Investor Research, LSN
RESI’s first Europe event in 2019 was a lively gathering, with RESI’s ecosystem of global early stage investors and technologies coming together with life science startups and regional hubs from Europe and beyond. RESI is now heading back to Europe for a Paris event on March 23rd. We’re excited to be back, and we’ve put together a content agenda full of focused investor sessions on relevant topics for the occasion, including the return of our regional-focused Europe Tech Hubs panel. In addition, we will once again feature early stage investors sharing their perspectives on the investment landscape in core areas including Early Stage Therapeutic Investors, AI in Healthcare, and Diagnostics, and key partners will discuss their strategies in panels such as Big Pharma, Family Offices/Angels, and China Cross Border Partnerships. The content will also include workshops dedicated to helping entrepreneurs learn how to develop their investor marketing, valuation strategy and negotiation skills. Our newest addition to the RESI Paris agenda is a full track of startup pitches, allowing companies to showcase their technologies in front of a panel of investors. Register here (link) for RESI Paris to see this content live and to meet one-on-one with investors in your space!
Leave a Reply